Bioventus Inc. reported $138.964 million in sales and $4.074 million in operating profit for the quarter ending September 30, 2024, which met both Wall Street’s expectations and management’s guidance.
Robert Claypoole, Bioventus’ president and chief executive officer and Mark Singleton, senior vice president and chief financial officer, reported during their quarterly earnings call continued growth in the third quarter as the business grows.
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
